骨肌减少症的关联机制及干预治疗
Associated Mechanisms and Interventions for Osteosarcopenia
DOI: 10.12677/acm.2025.1551584, PDF,   
作者: 袁良杰, 姜 平*:吉首大学医学院,湖南 吉首;张家界市人民医院骨科,湖南 张家界;郭 靖:吉首大学医学院,湖南 吉首
关键词: 肌少症骨质疏松骨肌减少症治疗Sarcopenia Osteoporosis Osteosarcopenia Treatment
摘要: 肌少症、骨质疏松是两种常见的老年退行性疾病,随着全球人口老龄化加剧,这两种疾病的发病率不断上升,严重影响老年人的生活质量。近年来研究发现,骨质疏松与肌少症在发病机制上存在密切联系,若二者同时存在则被称为“骨肌减少症”(osteosarcopenia),对于患上骨肌减少症的老年人来说,跌倒、骨折、住院及死亡率会大大地增高。本文将从发病机制和干预治疗等方面综述骨质疏松与肌少症的最新研究进展。
Abstract: Sarcopenia and osteoporosis are two prevalent age-related degenerative disorders. With the accelerating global aging population, the incidence of these conditions continues to rise, significantly impairing the quality of life in older adults. Recent studies have revealed a close pathophysiological link between osteoporosis and sarcopenia. The co-occurrence of both conditions is termed “osteosarcopenia”, which markedly increases the risks of falls, fractures, hospitalization, and mortality in affected elderly individuals. This article reviews the latest research advances in osteosarcopenia, with a focus on its underlying mechanisms and therapeutic interventions.
文章引用:袁良杰, 姜平, 郭靖. 骨肌减少症的关联机制及干预治疗[J]. 临床医学进展, 2025, 15(5): 1991-1998. https://doi.org/10.12677/acm.2025.1551584

参考文献

[1] Dawson, A. and Dennison, E. (2016) Measuring the Musculoskeletal Aging Phenotype. Maturitas, 93, 13-17. [Google Scholar] [CrossRef] [PubMed]
[2] 廖芋霖, 邢叔星. 肌肉减少症与骨质疏松症关联情况的研究进展[J]. 临床骨科杂志, 2025, 28(1): 146-151.
[3] 迟煜, 徐展望. 肌少-骨质疏松症的研究进展[J]. 中国中医药现代远程教育, 2025, 23(4): 150-152.
[4] 张青, 周华. 更年期女性肌少症的研究进展[J]. 中国现代医学杂志, 2024, 34(22): 43-48.
[5] Laskou, F., Patel, H.P., Cooper, C. and Dennison, E. (2021) A pas de deux of osteoporosis and sarcopenia: Osteosarcopenia. Climacteric, 25, 88-95. [Google Scholar] [CrossRef] [PubMed]
[6] World Health Organization (2004) WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level. Summary Meeting Report. WHO.
[7] Rosenberg, I.H. (2011) Sarcopenia: Origins and Clinical Relevance. Clinics in Geriatric Medicine, 27, 337-339. [Google Scholar] [CrossRef] [PubMed]
[8] Cruz-Jentoft, A.J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., et al. (2018) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age and Ageing, 48, 16-31. [Google Scholar] [CrossRef] [PubMed]
[9] Chen, L., Woo, J., Assantachai, P., Auyeung, T., Chou, M., Iijima, K., et al. (2020) Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21, 300-307. [Google Scholar] [CrossRef] [PubMed]
[10] Bruyère, O., Beaudart, C., Ethgen, O., Reginster, J. and Locquet, M. (2019) The Health Economics Burden of Sarcopenia: A Systematic Review. Maturitas, 119, 61-69. [Google Scholar] [CrossRef] [PubMed]
[11] Huo, Y.R., Suriyaarachchi, P., Gomez, F., Curcio, C.L., Boersma, D., Muir, S.W., et al. (2015) Phenotype of Osteosarcopenia in Older Individuals with a History of Falling. Journal of the American Medical Directors Association, 16, 290-295. [Google Scholar] [CrossRef] [PubMed]
[12] Locquet, M., Beaudart, C., Bruyère, O., Kanis, J.A., Delandsheere, L. and Reginster, J. (2018) Bone Health Assessment in Older People with or without Muscle Health Impairment. Osteoporosis International, 29, 1057-1067. [Google Scholar] [CrossRef] [PubMed]
[13] Maurel, D., Jähn, K. and Lara-Castillo, N. (2017) Muscle-Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies. Biomedicines, 5, Article 62. [Google Scholar] [CrossRef] [PubMed]
[14] Taniguchi, Y., Makizako, H., Kiyama, R., Tomioka, K., Nakai, Y., Kubozono, T., et al. (2019) The Association between Osteoporosis and Grip Strength and Skeletal Muscle Mass in Community-Dwelling Older Women. International Journal of Environmental Research and Public Health, 16, Article 1228. [Google Scholar] [CrossRef] [PubMed]
[15] Yu, C., Du, Y., Peng, Z., Ma, C., Fang, J., Ma, L., et al. (2023) Research Advances in Crosstalk between Muscle and Bone in Osteosarcopenia (Review). Experimental and Therapeutic Medicine, 25, Article No. 189. [Google Scholar] [CrossRef] [PubMed]
[16] Frost, H.M. (2003) Bone's Mechanostat: A 2003 Update. The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 275, 1081-1101. [Google Scholar] [CrossRef] [PubMed]
[17] Frost, H.M. (1999) Why Do Bone Strength and “Mass” in Aging Adults Become Unresponsive to Vigorous Exercise? Insights of the Utah Paradigm. Journal of Bone and Mineral Metabolism, 17, 90-97. [Google Scholar] [CrossRef] [PubMed]
[18] Li, G., Zhang, L., Ning, K., Yang, B., Acosta, F.M., Shang, P., et al. (2021) Osteocytic Connexin43 Channels Regulate Bone-Muscle Crosstalk. Cells, 10, Article 237. [Google Scholar] [CrossRef] [PubMed]
[19] Kawao, N., Morita, H., Iemura, S., et al. (2020) Roles of Dkk2 in the Linkage from Muscle to Bone During Mechanical Unloading in Mice. International Journal of Molecular Sciences, 21, Article 2547.
[20] Kirk, B., Feehan, J., Lombardi, G., et al. (2020) Muscle, Bone, and Fat Crosstalk: The Biological Role of Myokines, Osteokines, and Adipokines. Current Osteoporosis Reports, 18, 388-400.
[21] Mancinelli, R., Checcaglini, F., Coscia, F., Gigliotti, P., Fulle, S. and Fanò-Illic, G. (2021) Biological Aspects of Selected Myokines in Skeletal Muscle: Focus on Aging. International Journal of Molecular Sciences, 22, Article 8520. [Google Scholar] [CrossRef] [PubMed]
[22] Pedersen, B.K. (2013) Muscle as a Secretory Organ. Comprehensive Physiology, 3, 1337-1362. [Google Scholar] [CrossRef
[23] Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., et al. (2012) A Pgc1-α-Dependent Myokine That Drives Brown-Fat-Like Development of White Fat and Thermogenesis. Nature, 481, 463-468. [Google Scholar] [CrossRef] [PubMed]
[24] Reza, M.M., Subramaniyam, N., Sim, C.M., Ge, X., Sathiakumar, D., McFarlane, C., et al. (2017) Irisin Is a Pro-Myogenic Factor That Induces Skeletal Muscle Hypertrophy and Rescues Denervation-Induced Atrophy. Nature Communications, 8, Article No. 1104. [Google Scholar] [CrossRef] [PubMed]
[25] Yuan, W. and Song, C. (2022) Crosstalk between Bone and Other Organs. Medical Review, 2, 331-348. [Google Scholar] [CrossRef] [PubMed]
[26] Polyzos, S.A., Anastasilakis, A.D., Efstathiadou, Z.A., Makras, P., Perakakis, N., Kountouras, J., et al. (2017) Irisin in Metabolic Diseases. Endocrine, 59, 260-274. [Google Scholar] [CrossRef] [PubMed]
[27] 徐帅, 赵常红, 徐道明, 等. 肌骨交互视阈下肌骨共减综合症的生物学机制及其运动干预研究进展[J]. 中国体育科技, 2022, 58(5): 75-83.
[28] Jürimäe, J., Karvelyte, V., Remmel, L., Tamm, A., Purge, P., Gruodyte-Raciene, R., et al. (2021) Serum Sclerostin Concentration Is Associated with Specific Adipose, Muscle and Bone Tissue Markers in Lean Adolescent Females with Increased Physical Activity. Journal of Pediatric Endocrinology and Metabolism, 34, 755-761. [Google Scholar] [CrossRef] [PubMed]
[29] Komori, T. (2020) Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle. International Journal of Molecular Sciences, 21, Article 7513. [Google Scholar] [CrossRef] [PubMed]
[30] Ballesteros, J., Rivas, D. and Duque, G. (2023) The Role of the Kynurenine Pathway in the Pathophysiology of Frailty, Sarcopenia, and Osteoporosis. Nutrients, 15, Article 3132. [Google Scholar] [CrossRef] [PubMed]
[31] Oh, J., Sinha, I., Tan, K.Y., Rosner, B., Dreyfuss, J.M., Gjata, O., et al. (2016) Age-associated NF-κB Signaling in Myofibers Alters the Satellite Cell Niche and Re-Strains Muscle Stem Cell Function. Aging, 8, 2871-2896. [Google Scholar] [CrossRef] [PubMed]
[32] Bae, S., Kim, K., Kang, K., Kim, H., Lee, M., Oh, B., et al. (2022) Rankl-Responsive Epigenetic Mechanism Reprograms Macrophages into Bone-Resorbing Osteoclasts. Cellular & Molecular Immunology, 20, 94-109. [Google Scholar] [CrossRef] [PubMed]
[33] 中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J]. 中华骨质疏松和骨矿盐疾病杂志, 2019, 12(4): 317-318.
[34] Kitajima, Y. and Ono, Y. (2016) Estrogens Maintain Skeletal Muscle and Satellite Cell Functions. Journal of Endocrinology, 229, 267-275. [Google Scholar] [CrossRef] [PubMed]
[35] Lai, S., Collins, B.C., Colson, B.A., Kararigas, G. and Lowe, D.A. (2016) Estradiol Modulates Myosin Regulatory Light Chain Phosphorylation and Contractility in Skeletal Muscle of Female Mice. American Journal of Physiology-Endocrinology and Metabolism, 310, E724-E733. [Google Scholar] [CrossRef] [PubMed]
[36] 赵瑞, 林贤灿, 黄宏兴, 等. “后天养先天”理论探讨肠道菌群在肌少-骨质疏松症中的作用[J]. 中国骨质疏松杂志, 2023, 29(8): 1172-1176.
[37] Cento, A.S., Leigheb, M., Caretti, G. and Penna, F. (2022) Exercise and Exercise Mimetics for the Treatment of Musculoskeletal Disorders. Current Osteoporosis Reports, 20, 249-259. [Google Scholar] [CrossRef] [PubMed]
[38] Weng, W., Li, H. and Zhu, S. (2022) An Overlooked Bone Metabolic Disorder: Cigarette Smoking-Induced Osteoporosis. Genes, 13, Article 806. [Google Scholar] [CrossRef] [PubMed]
[39] Morrison, M., Halson, S.L., Weakley, J. and Hawley, J.A. (2022) Sleep, Circadian Biology and Skeletal Muscle Interactions: Implications for Metabolic Health. Sleep Medicine Reviews, 66, Article 101700. [Google Scholar] [CrossRef] [PubMed]
[40] 黄宏兴, 史晓林, 李盛华, 等. 肌少-骨质疏松症专家共识[J]. 中国骨质疏松杂志, 2022, 28(11): 1561-1570.
[41] 周坚, 张涛, 周威力, 等. 抗阻训练对骨质疏松并肌少症患者股四头肌质量及膝关节功能的影响[J/OL]. 中国组织工程研究, 1-6.
http://kns.cnki.net/kcms/detail/21.1581.r.20250217.1252.006.html, 2025-04-12.
[42] Harijanto, C., Lim, A., Vogrin, S. and Duque, G. (2021) Does Whole-Body Vibration Training Have a Concurrent Effect on Bone and Muscle Health? A Systematic Review and Meta-Analysis. Gerontology, 68, 601-611. [Google Scholar] [CrossRef] [PubMed]
[43] 刘静, 段景宜, 高海英. 肌少症与骨质疏松的相关性研究进展[J]. 中国临床保健杂志, 2022, 25(5): 593-599.
[44] Bae, Y. (2020) Fruit Intake and Osteosarcopenic Obesity in Korean Postmenopausal Women Aged 50-64 Years. Maturitas, 134, 41-46. [Google Scholar] [CrossRef] [PubMed]
[45] Mazzola, G., Rondanelli, M., Baron, G., et al. (2024) Bergamot (Citrus bergamia), a (Poly) Phenol-Rich Source for Improving Osteosarcopenic Obesity: A Systematic Review. Foods, 13, Article 3422.
[46] Li, S., Zou, J., Ran, J., Wang, L., Nie, G., Liu, Y., et al. (2024) Advances in the Study of Denosumab Treatment for Osteoporosis and Sarcopenia in the Chinese Middle-Aged and Elderly Population. International Journal of General Medicine, 17, 6089-6099. [Google Scholar] [CrossRef] [PubMed]
[47] Girgis, C.M., Mokbel, N. and DiGirolamo, D.J. (2014) Therapies for Musculoskeletal Disease: Can We Treat Two Birds with One Stone? Current Osteoporosis Reports, 12, 142-153. [Google Scholar] [CrossRef] [PubMed]
[48] Altowati, M.A., Shepherd, S., McGrogan, P., Russell, R.K., Ahmed, S.F. and Wong, S.C. (2018) Effects of Recombinant Human Growth Hormone in Children with Crohn’s Disease on the Muscle-Bone Unit: A Preliminary Study. Hormone Research in Paediatrics, 90, 128-131. [Google Scholar] [CrossRef] [PubMed]
[49] Pawlikowska-Haddal, A. (2013) Growth Hormone Therapy with Norditropin (Somatropin) in Growth Hormone Deficiency. Expert Opinion on Biological Therapy, 13, 927-932.
[50] 张通海, 王礼宁, 马勇, 等. 基于五体理论探讨五体与肌少-骨质疏松症的关系及肌少-骨质疏松症的治疗[J]. 中医正骨, 2024, 36(7): 51-54.